TVM Capital Life Science has announced the final close of TVM Life Sciences Investments II (TVM LSI II) on $478m.

TVM LSI II was substantially oversubscribed, said a press release from the Munich, Germany, and Montreal, Canada-based life sciences venture capital firm.

The committed capital was raised from high-profile international investors, including Eli Lill